Last 48 quarters of trend data · Real Estate · REIT - Healthcare Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has expanded 29.4% YoY to 19.3x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | — | — | 50.43 | 17.07 | 25.69 | 22.79 | 35.79 | 38.50 | 33.57 | 48.47 | — | 32.26 | — |
| — | — | +40.9% | -55.7% | -23.5% | -53.0% | — | +19.3% | — | — | — | -33.0% | — | |
| P/S Ratio | 6.68 | 5.65 | 5.97 | 5.87 | 5.72 | 5.69 | 6.20 | 5.11 | 5.17 | 5.09 | 4.99 | 4.26 | 4.14 |
| — | -0.7% | -3.6% | +14.9% | +10.6% | +11.8% | +24.3% | +20.0% | +24.8% | -40.3% | -10.3% | -19.3% | -24.1% | |
| P/B Ratio | 1.78 | 1.70 | 1.61 | 1.64 | 1.55 | 1.51 | 1.61 | 1.30 | 1.25 | 1.19 | 1.12 | 0.93 | 0.89 |
| — | +12.0% | -0.1% | +25.7% | +24.7% | +27.5% | +43.0% | +40.4% | +39.5% | +26.4% | +19.0% | -4.8% | -12.9% | |
| P/FCF | 14.84 | — | 11.35 | 13.72 | 13.08 | 12.98 | 11.29 | 11.23 | 16.32 | 10.57 | 311.37 | 9.72 | 9.73 |
| — | — | +0.5% | +22.2% | -19.9% | +22.8% | -96.4% | +15.6% | +67.7% | -0.5% | +4357.6% | -8.0% | -28.7% | |
| EV / EBITDA | 18.68 | 19.29 | 16.09 | 14.82 | 14.87 | 14.91 | 15.98 | 13.90 | 14.58 | 14.75 | 24.53 | 8.84 | 8.14 |
| — | +29.4% | +0.6% | +6.7% | +2.0% | +1.1% | -34.8% | +57.2% | +79.0% | -20.2% | +136.8% | -6.0% | -13.7% | |
| EV / EBIT | — | — | 33.52 | 18.30 | 24.31 | 19.71 | 29.02 | 28.10 | 26.68 | 31.44 | 103.04 | 22.37 | 25.51 |
| — | — | +15.5% | -34.9% | -8.9% | -37.3% | -71.8% | +25.7% | +4.6% | — | +182.8% | -4.1% | +11.7% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 63.3% | 67.7% | 67.3% | 67.2% | 67.1% | 68.9% | 67.6% | 69.5% | 69.8% | 69.4% | 70.3% |
| — | — | -5.6% | -1.8% | -0.4% | -3.3% | -3.8% | -0.7% | -3.9% | +45.4% | +0.4% | -7.3% | -6.9% | |
| Operating Margin | — | — | 31.3% | 38.0% | 36.7% | 36.9% | 36.2% | 38.0% | 34.8% | 33.2% | — | 63.4% | 63.8% |
| — | — | -13.3% | +0.1% | +5.6% | +11.0% | — | -40.1% | -45.5% | -4.7% | — | -8.3% | -7.5% | |
| Net Margin | 20.0% | 12.5% | 11.9% | 34.7% | 22.0% | 25.6% | 16.7% | 13.6% | 15.7% | 10.5% | -9.3% | 13.2% | -5.9% |
| — | -51.2% | -29.1% | +154.6% | +39.5% | +143.9% | +279.1% | +3.1% | +366.3% | +110.4% | +74.5% | +20.5% | -123.0% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.6% | 0.9% | 0.8% | 2.4% | 1.5% | 1.7% | 1.1% | 0.9% | 0.9% | 0.6% | -0.5% | 0.7% | -0.3% |
| — | -45.0% | -24.8% | +179.2% | +57.1% | +181.4% | +308.2% | +21.2% | +399.7% | +122.3% | +66.1% | +42.2% | -126.1% | |
| ROA | 2.9% | 0.5% | 0.4% | 1.2% | 0.8% | 0.9% | 0.6% | 0.4% | 0.5% | 0.3% | -0.3% | 0.4% | -0.2% |
| — | -45.3% | -25.6% | +177.6% | +56.8% | +174.6% | +300.7% | +16.9% | +390.6% | +121.7% | +67.3% | +34.8% | -124.5% | |
| ROIC | — | — | 0.9% | 1.1% | 1.0% | 1.0% | 0.9% | 1.0% | 0.8% | 0.8% | — | 1.4% | 1.4% |
| — | — | -7.3% | +9.4% | +18.4% | +25.3% | — | -32.1% | -40.6% | +99.4% | — | +2.7% | -1.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Sabra Health Care REIT, Inc.'s Debt/EBITDA ratio is 16.2x, down from 24.2x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 83.5% YoY to 0.15x, tightening the short-term liquidity position.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.45 | 0.45 | 0.92 | 0.92 | 0.90 | 0.89 | 0.91 | 0.90 | 0.90 | 0.87 | 0.83 | 0.84 | 0.82 |
| — | -50.1% | +1.6% | +3.0% | -0.7% | +2.1% | +9.6% | +7.3% | +10.1% | +4.7% | +7.0% | +9.7% | +14.4% | |
| Debt / EBITDA | 3.69 | 16.24 | 24.19 | 21.67 | 21.82 | 22.30 | 23.33 | 22.79 | 24.73 | 25.17 | 42.00 | 16.85 | 15.70 |
| — | -27.2% | +3.7% | -4.9% | -11.8% | -11.4% | -44.5% | +35.3% | +57.5% | -28.3% | +123.5% | +0.9% | +0.7% | |
| Current Ratio | 0.15 | 0.15 | 2.59 | 2.27 | 1.39 | 0.88 | 1.55 | 1.67 | 0.83 | 2.35 | — | — | — |
| — | -83.5% | +66.7% | +35.9% | +67.4% | -62.4% | — | — | — | +294.6% | — | — | — | |
| Quick Ratio | 0.15 | 0.15 | 2.59 | 2.27 | 1.39 | 0.88 | 1.55 | 1.67 | 0.83 | 2.35 | — | — | — |
| — | -83.5% | +66.7% | +35.9% | +67.4% | -62.4% | — | — | — | +294.6% | — | — | — | |
| Interest Coverage | — | — | 1.92 | 2.61 | 2.49 | 2.40 | 2.18 | 2.28 | 2.04 | 1.25 | — | 3.59 | 3.59 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonQuarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Sabra Health Care REIT, Inc.'s business trajectory between earnings reports.